Italy introduces compulsory vaccination for those over the age of 50

6:06 pm: None of the three synthetic antibody treatments work against Omicron

French health authorities on Wednesday significantly restricted the scope of anti-Covid treatments with synthetic antibodies, noting that some of them had not proven sufficiently effective against the new variant of Omicron.

For an already announced Covid treatment, none of the three treatments available so far are effective if the infection is caused by an omicron variant, the ANSM said in a press release. Only one, AstraZeneca Evusheld, can be used to prevent infection with this type.

Until recently, three antibody treatments were allowed in France against Covid: Ronapreve by Roche, bamlanivimab/etesivimab combination by Eli Lilly and more recently Evusheld.

These treatments target specific patient groups:People who already have severe forms, to prevent them from deteriorating and those For whom the vaccination does not work poorly because of their weak immune system: transplant recipients, dialysis patients, transplant recipients, have some types of cancer or are taking certain treatments.